CoinShares International Limited ("CoinShares" or the "Company") (Nasdaq Stockholm Market: CS; US OTCQX: CNSRF), a global investment firm specializing in digital assets, is pleased to announce that ...

The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Furthermore, ...

ReGen III is also pleased to announce its Brazilian patent application (1120210154531) has been granted, with the corresponding Letters Patent to be issued by the Brazilian National Institute of ...

The global neuroendocrine carcinoma treatment market is likely to generate revenue amounting to USD 1,976 million in 2024. Over the assessment period, the industry is projected to expand at an 8.1% ...

BMW Motorrad dealerships were ranked highest in the 2025 Pied Piper PSI ® Service Telephone Effectiveness ® (STE ®) ...

Winning an international arbitration may feel like the end of a long and contentious legal battle. However, when it comes to ...

Australia is undergoing rapid population growth, but the way we’re planning for it (or rather, not planning for it) is setting us up for failure.

(EBC) patients receiving Kisqali in 1-year post-treatment analysis1Tolerability remained consistent, with fewer treatment discontinuations due to adverse events among pre-menopausal patients1Rising br ...